Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FK947
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,412
Award facts
- Contract value 100% obligated
- $14,411.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 15, 2026, for Zepbound 2.5 mg/0.5 mL pens with a ceiling value of $14,411.93. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Zepbound is a GLP-1 receptor agonist medication used for weight management, and this delivery order fulfills military healthcare supply needs through the established pharmaceutical prime vendor relationship. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (also known as AmerisourceBergen), which holds the parent IDC with DLA. The contract's completion date is January 16, 2026, with performance occurring at the company's Conshohocken, Pennsylvania facility, and reflects the company's established capability to supply specialized pharmaceutical products on a competitively awarded basis to federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26FK947?
SPE2DR26FK947 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FK947 worth?
The government has obligated $14,412 on SPE2DR26FK947.
Is contract SPE2DR26FK947 an order under another contract?
Yes. SPE2DR26FK947 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK947 competed?
The extent of competition for SPE2DR26FK947 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award